Covid And ENT

The 2019 novel coronavirus disease (COVID-19) is a highly contagious zoonosis produced by SARS-CoV-2 that is spread human-to-human by respiratory secretions. It was declared by the WHO as a public health emergency. The most susceptible populations, needing mechanical ventilation, are the elderly and people with associated comorbidities. There is an important risk of contagion for anaesthetists, dentists, head and neck surgeons, maxillofacial surgeons, ophthalmologists, and otolaryngologists. Health workers represent between 3.8% and 20% of the infected population; some 15% will develop severe complaints and among them, many will lose their lives. A large number of patients do not have overt signs and symptoms (fever/respiratory), yet pose a real risk to surgeons (who should know this fact and must therefore apply respiratory protective strategies for all patients they encounter).

  • Track 1-1 Guidance for otolaryngology health care workers
  • Track 2-2 Tracheotomy recommendations during the COVID-19 pandemic
  • Track 3-3 Management of Loss of Sense of Smell (Anosmia) Associated with COVID-19 (SARS-CoV-2 Infection)
  • Track 4-4 N95 Respirators (HEPA or High-Efficiency-Particulate-Air Filter Respirators) as Personal Protective Equipment (PPE)
  • Track 5-5 Transnasal Laryngoscopy in COVID-19 Era
  • Track 6-6 Transnasal injection to vocal fold in COVID-19 Era
  • Track 7-7 Negative Pressure Face Shield (NPFS) for Transnasal Laryngoscopy to Mitigate Dispersion of Bioaerosol in COVID Era
  • Track 8-8 Negative Pressure Face Shield (NPFS) for Transnasal Laryngoscopy KTP Laser Treatment of Hemorrhagic Polyp in COVID Era

Related Conference of Dentistry